Form 4: Celanese Corp: Officer Mark Christopher Murray Acquires Stock Options

Mark Christopher Murray, SVP Acetyls at Celanese Corp, reports the acquisition of 19,027 nonqualified stock options.

Summary

• On February 26, 2025, Mark Christopher Murray, SVP Acetyls at Celanese Corp, acquired 19,027 nonqualified stock options.
• These options, granted under the company's 2018 Global Incentive Plan, as amended, have an exercise price of $53.96.
• The options vest in three annual installments of 33%, 33%, and 34% beginning February 15, 2026.
• The options expire on February 25, 2035.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reflects a standard executive compensation practice. It's neither overwhelmingly positive nor negative.

Positives

• The granting of stock options aligns the officer's interests with those of the shareholders, incentivizing performance and company growth.

Industry Context

This is a standard practice for publicly traded companies to incentivize their executives with stock options, aligning their interests with shareholders.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in the chemical industry, similar to practices at companies like Dow Chemical and BASF.
• Vesting schedules of three years are typical, aligning with industry norms for retaining key personnel.

Stakeholder Impact

• The granting of stock options can positively impact shareholders by aligning management's interests with the company's long-term success.

Key Dates